Condromed 200 mg / 250 mg

Condromed 200 mg / 250 mg is a medicine authorised by Swissmedic under authorisation number 68626. The authorisation holder is IBSA Institut Biochimique SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 January 2023 and the authorisation is limited until 10 January 2028. The export lists no ATC code for this medicine.

  • Dispensing category B
  • Authorisation number 68626
  • Biotechnological medicines
Authorisation data
Authorisation number68626
NameCondromed 200 mg / 250 mg
Full nameCondromed 200 mg / 250 mg, Hartkapseln
Authorisation holderIBSA Institut Biochimique SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codenot stated
First authorisation11 January 2023
Authorisation validity10 January 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Condromed 200 mg / 250 mg, HartkapselnB11 January 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Condromed 200 mg / 250 mg authorised in Switzerland?

Yes. Condromed 200 mg / 250 mg is authorised by Swissmedic under authorisation number 68626, data as of 01 September 2026. The authorisation is limited until 10 January 2028.

Which dispensing category does Condromed 200 mg / 250 mg have?

Condromed 200 mg / 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Condromed 200 mg / 250 mg?

The authorisation holder is IBSA Institut Biochimique SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com